MAP2K3 Monoclonal Antibody + Cell Lysate Kit
Applications
Reactivity
| Overview | |
| Catalog # | bsm-90041R |
| Product Name | MAP2K3 Monoclonal Antibody + Cell Lysate Kit |
| Applications | WB, FCM, IC |
| Specificity | Knockdown Validated |
| Reactivity | Human, Mouse, Rat |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | A synthesized peptide derived from human MEK3 |
| Immunogen Range | 120-347/347 |
| Clonality | Monoclonal |
| Clone # | 23GB2420 |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Affinity Purified |
| Storage Buffer | Supplied in PBS (pH 7.4) containing 50% glycerol, and 0.02% sodium azide. |
| Storage Condition | -20 °C |
| Target | |
| Gene ID | 5606 |
| Swiss Prot | P46734 |
| Synonyms | MAP2K3; Mitogen-Activated Protein Kinase Kinase 3; MEK3; MKK3; Stress-Activated Protein Kinase Kinase 2; MAP Kinase Kinase 3; MAPK/ERK Kinase 3; MAPKK3; SAPKK2; PRKMK3; Dual Specificity Mitogen-Activated Protein Kinase Kinase 3; SAPK Kinase 2; EC 2.7.12.2; SAPKK-2; MAPKK 3; MEK 3; Dual Specificity Mitogen Activated Protein Kinase Kinase 3; SKK2 |
| Background | Dual specificity kinase. Is activated by cytokines and environmental stress in vivo. Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinase p38. Part of a signaling cascade that begins with the activation of the adrenergic receptor ADRA1B and leads to the activation of MAPK14. Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution | |
| WB | : 1:1000-1:5000 |
| FCM | FCM: 1:2000 |
| IC | IC: 1:1000 |
Powered by Bioz